Background Weight gain is often considered a side effect of combination hormonal
contraceptives, and many women and clinicians believe that an association exists. Concern …

Objectives To provide a comprehensive and objective summary of contraceptive failure rates
for a variety of methods based on a systematic review of the literature. Methods Medline and …

The acceptability of the combined contraceptive vaginal ring, NuvaRing®, was assessed
during two trials conducted in North America and Europe. Women completed a …

This open-label, randomized, Phase III study compared the efficacy and tolerability of and
compliance with NuvaRing, a combined contraceptive vaginal ring releasing 15 μg of …

Aims Breakthrough bleeding or even unwanted pregnancies have been reported in women
during concomitant therapy with oral contraceptives and St John's wort extract. The aim of …

目的: 探讨人工流产后应用复方短效口服避孕药一妈富隆的临床价值. 方法: 将240
例人工流产者随机分成两组, 观察组(120 例) 于人工流产后服用妈富隆, 抗生素及益母膏 …

OBJECTIVE: Many women and clinicians believe that combination estrogen–progestin
contraceptive use can lead to weight gain. This concern can deter women from starting …

BACKGROUND: This trial was conducted to compare cycle control with vaginal ring a
combined contraceptive vaginal ring, and a combined oral contraceptive (COC) delivering …

Abnormal bleeding is a significant health problem, especially during adolescence and
before menopause when anovulatory cycles are common. Curettage is rarely necessary to …

BACKGROUND: New low-dose formulations of combination oral contraceptives (COCs) are
safe and effective, but they may be associated with an increased risk of breakthrough …